FORMULATION DEVELOPMENT AND CHARACTERIZATION OF NOVEL ANTIPSORIATIC GEL FOR TOPICAL DRUG DELIVERY SYSYEM

Studies using FTIR spectroscopy verified that the medicine and excipients are compatible. Dimethyl sulfoxide, Carbopol 10NF, propylene glycol, glycerol, methyl paraben, propyl paraben, and water were used to make the gel. Out of all the formulations, the Optimized formulation (F3) is the most effective. The prepared gel demonstrated satisfactory physical characteristics, including assay (97%w/w) and pH (4.99). Additionally, 98.2% of the medication was released in 12 hours according to in vitro diffusion experiments. For one, two, and three months, the formulation was loaded for stability at accelerated conditions of 40°C/75%RH and 30°C/65%RH. The optimized formulation (F3) has demonstrated satisfactory in vitro performance and good stability.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-10
DOI
https://doi.org/10.5281/zenodo.20120852
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FORMULATION DEVELOPMENT AND CHARACTERIZATION OF NOVEL ANTIPSORIATIC GEL FOR TOPICAL DRUG DELIVERY SYSYEM

Dr. P. M. Pimpalshende Prajkta Diwakar Durge*
Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

FORMULATION DEVELOPMENT AND CHARACTERIZATION OF NOVEL ANTIPSORIATIC GEL FOR TOPICAL DRUG DELIVERY SYSYEM

Dr. P. M. Pimpalshende Prajkta Diwakar Durge*
article en

Abstract

Studies using FTIR spectroscopy verified that the medicine and excipients are compatible. Dimethyl sulfoxide, Carbopol 10NF, propylene glycol, glycerol, methyl paraben, propyl paraben, and water were used to make the gel. Out of all the formulations, the Optimized formulation (F3) is the most effective. The prepared gel demonstrated satisfactory physical characteristics, including assay (97%w/w) and pH (4.99). Additionally, 98.2% of the medication was released in 12 hours according to in vitro diffusion experiments. For one, two, and three months, the formulation was loaded for stability at accelerated conditions of 40°C/75%RH and 30°C/65%RH. The optimized formulation (F3) has demonstrated satisfactory in vitro performance and good stability.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 6%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.